JSLLNSEJeena Sikho Lifecare LimitedMediumPositive
Announced Wed, 3 Jun · 17:07 IST

Jeena Sikho Lifecare Limited Has Informed the Exchange About Receipt of NABH Accreditation for Bhopal Hospital.

Regulatory Product ApprovalBusiness Updates View source PDF

JSLL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.1%1-day move
₹699.90
prior close
₹697.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+5.3+3.2+1.6+2.3-10.1-12.1-13.0-16.6-14.8-12.8-14.0-19.7
Up moveDown movePending
AI summary

Jeena Sikho Lifecare has informed the stock exchange that its Bhopal hospital has received NABH (National Accreditation Board for Hospitals and Healthcare Enterprises) accreditation. NABH is a widely recognised quality and patient safety certification for hospitals in India. This accreditation signals that the hospital meets nationally benchmarked standards for healthcare delivery, clinical protocols, and operational quality. The Bhopal facility is part of the company's network of healthcare establishments under the Jeena Sikho brand.

Likely market impact

This is a positive operational and credibility milestone that strengthens the hospital's brand value and could help attract more patients and insurance tie-ups, though it is a quality certification rather than a direct revenue trigger. Shareholders may view it as supportive of the company's expansion and quality positioning in the long term.